NIH – The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required)

September 9, 2019 by


This Funding Opportunity Announcement (FOA) invites applications from clinical investigators to participate in the National Drug Abuse Treatment Clinical Trials Network (CTN). NIDA intends to continue to develop and test interventions to address a variety of substance use problems via collaborative partnerships among NIDA, clinical research investigators, and healthcare providers and institutions.


The CTN currently is comprised of two coordinating centers and 18 Nodes. Each Node is a primary performance site, with numerous affiliated clinical research sites. The CTN program is administered within NIDA through the Center for the Clinical Trials Network (CCTN). NIDA plans to continue supporting the CTN research infrastructure to build on the broad portfolio of research conducted in the CTN. Applications proposing new Nodes and continued support of existing Nodes are encouraged. Applications proposing Multiple Principal Investigator (MPI) collaborations, including collaborations among institutions in different states, are encouraged. NIDA has an interest in extending the reach of the CTN to regions of the country that are heavily impacted by substance use and not currently represented in the Network.

Key Dates:

Posted: September 4, 2019

Open Date (Earliest Submission Date): October 15, 2019

Letter of Intent Due Date(s): 30 days prior to the application due date
Application Due Date(s): November 15, 2019.
Web-link for more information:

Filed Under: Funding Opportunities